Worried About Pfizer's Post-Pandemic Growth? These 14 Words from Pfizer's CEO Should Reassure You.
Pfizer (NYSE: PFE) recently reported billions of dollars in revenue last year thanks to its coronavirus vaccine. And the big pharma company predicts its vaccine and new coronavirus treatment together will bring in $54 billion this year. But that's not all. Pfizer's entire portfolio of products may bring annual revenue past the $100 billion mark.
Sounds pretty impressive. Still, some investors worry about Pfizer's growth after the pandemic. The risk is a major drop in coronavirus vaccine sales. And this could come at a time when some of Pfizer's biggest drugs begin to face generic competition. Now here's some good news. These concerns about Pfizer's future may be greatly overdone. Pfizer CEO Albert Bourla recently pronounced 14 words that should reassure Pfizer investors -- and those looking to get on the shares.
Image source: Getty Images.
Source Fool.com
